The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Signaling pathways weigh in on decisions to make or break skeletal muscle
Abstract
PURPOSE OF REVIEW: Regulation of muscle size is essential for proper development and homeostasis of adult musculature. This regulation is mediated in large part by signal transduction pathways that promote the synthesis or breakdown of skeletal muscle. PI(3)K/Akt, myostatin and NF-kappaB represent three such pathways that will be the focus of this review. RECENT FINDINGS: Recent reports solidify the requirement of the PI(3)K/Akt pathway in the regulation of muscle hypertrophy. In response to IGF-1, Akt activates downstream effectors, mTOR and p70S6K to stimulate protein synthesis thereby increasing the cytoplasmic compartment in muscle fibers. Tsc2 was also identified as a novel Akt target, whose phosphorylation and inactivation by Akt may lead to an increase in cell size. The mechanisms by which myostatin functions in muscle wasting was recently explored using in-vitro assays of myogenesis. Myostatin was found to repress myogenesis by inhibiting the synthesis and activity of MyoD. Paradoxically, myostatin expression is itself regulated by MyoD binding to the myostatin promoter. The NF-kappaB transcription factor also functions as a negative regulator of myogenesis by inhibiting MyoD. Chronic activation of NF-kappaB has been associated with muscle wasting, but the mechanisms by which this regulation occurs remain for the most part unknown. SUMMARY: Recent cell culture and animal studies have provided insight on the mechanisms by which Akt, myostatin, and NF-kappaB signaling pathways regulate muscle size. Clinical intervention to boost Akt signaling or modulate myostatin and NF-kappaB activities may prove useful in diseases associated with chronic muscle wasting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which is known to promote skeletal muscle growth [25].”
From Effect of Ecdysterone on the Hepatic Transcriptome and Lipid Metabolism in Lean and Obese Zucker Rats (2021) · cites this paper as [25]
Citations
Cites
2 retracted
Positive Feedback Regulation between Akt2 and MyoD during Muscle Differentiation
Kaneko, S., Feldman, R. I., Yu, L., Wu, Z., Gritsko, T. M., Shelley, S. A., Nicosia, S. V., Nobori, T., & Cheng, J. Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201733200 · Cited by 55
RetractedKaneko, S., Feldman, R. I., Yu, L., Wu, Z., Gritsko, T. M., Shelley, S. A., Nicosia, S. V., Nobori, T., & Cheng, J. Q. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a116.201733 · Cited by 53
RetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Signal transduction by tumor necrosis factor and its relatives.
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,741
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
D, D. C. G., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,304
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00477-x · Cited by 951
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
D, D. C. G., Mayo, M. W., Madrid, L. V., Wang, C., & Baldwin, A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 922
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P. A., Esquela‐Kerscher, A., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S. (2002) · Science · doi:10.1126/science.1069525 · Cited by 908
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
The molecular regulation of myogenesis
Sabourin, L. A., & Rudnicki, M. A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.570103.x · Cited by 720
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
Glass, D. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-87 · Cited by 694
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
Ruan, H., Hacohen, N., Golub, T. R., Parijs, L. V., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1319 · Cited by 543
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Whittemore, L.-A., Song, K., Li, X., Aghajanian, J. D., Davies, M. V., Girgenrath, S., Hill, J. J., Jalenak, M., Kelley, P. E., Knight, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02953-4 · Cited by 512
Li, Y., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 502
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 490
Grobet, L., Poncelet, D. A., Royo, L. J., Brouwers, B., Pirottin, D., Michaux, C., Ménissier, F., Zanotti, M., Dunner, S., & Georges, M. (1998) · Mammalian Genome · doi:10.1007/s003359900727 · Cited by 471
NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes
Li, Y.-P., & Reid, M. B. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1165 · Cited by 451
Molecular mechanisms modulating muscle mass
Glass, D. J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00138-2 · Cited by 444
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., Schols, A. M. W. J., KELDERS, M. C. J. M., Wouters, E. F. �., & Janssen-Heininger, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 436
Ma, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., González-Cadavid, N. F., Arias, J., & Salehian, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2002 · Cited by 416
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & González-Cadavid, N. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
Functional antagonism between c-Jun and MyoD proteins: A direct physical association
Bengal, E., Ransone, L. J., Scharfmann, R., Dwarki, V., Tapscott, S. J., Weintraub, H. M., & Verma, I. M. (1992) · Cell · doi:10.1016/0092-8674(92)90187-h · Cited by 385
Carlson, C. J., Booth, F. W., & Gordon, S. E. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.2.r601 · Cited by 358
Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin
Joulia-Ekaza, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., & Cabello, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00074-0 · Cited by 338
Bergstrom, D. A., Penn, B. H., Strand, A. D., Perry, R. L., Rudnicki, M. A., & Tapscott, S. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00481-1 · Cited by 332
Kumar, A., & Boriek, A. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0542com · Cited by 303
Activation of an alternative NF‐ΚB pathway in skeletal muscle during disuse atrophy
Hunter, R. B., Stevenson, E. J., Koncarevic, A., Mitchell-Felton, H., Essig, D. A., & Kandarian, S. C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0866com · Cited by 287
Baeza-Raja, B., & Muñoz-Cánoves, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0585 · Cited by 247
Ji, S., Losinski, R. L., Cornelius, S. G., Frank, G. R., Willis, G. M., Gerrard, D. E., Depreux, F. F. S., & Spurlock, M. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.4.r1265 · Cited by 246
The role of cytokines in cancer cachexia
Argilés, J. M. A., & López-Soriano, F. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199905)19:3 · Cited by 234
Ladner, K. J., Caligiuri, M. A., & D, D. C. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207129200 · Cited by 233
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G., & McNally, E. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01570-2 · Cited by 227
Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival
Fujio, Y., Guo, K. Y., Mano, T., Mitsuuchi, Y., Testa, J. R., & Walsh, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5073 · Cited by 213
Thaloor, D., Miller, K. J., Gephart, J., Mitchell, P. O., & Pavlath, G. K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c320 · Cited by 211
Ma, K., Mallidis, C., Artaza, J., Taylor, W. E., González-Cadavid, N. F., & Bhasin, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1128 · Cited by 208
Hribal, M. L., Nakae, J., Kitamura, T., Shutter, J. R., & Accili, D. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212107 · Cited by 203
Expression of myostatin pro domain results in muscular transgenic mice
Yang, J., Ratovitski, T., Brady, J. P., Solomon, M. B., Wells, K. D., & Wall, R. J. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1097 · Cited by 177
FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts
Bois, P. R. J., & Grosveld, G. C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg116 · Cited by 168
The Myostatin Gene Is a Downstream Target Gene of Basic Helix-Loop-Helix Transcription Factor MyoD
Spiller, M. P., Kambadur, R., Jeanplong, F., Thomas, M., Martyn, J. K., Bass, J. J., & Sharma, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7066-7082.2002 · Cited by 166
A deletion in the myostatin gene causes the compact ( Cmpt ) hypermuscular mutation in mice
Szabó, G., Dallmann, G., Müller, G., Patthy, L., Soller, M., & Varga, L. (1998) · Mammalian Genome · doi:10.1007/s003359900843 · Cited by 161
Cahlin, C., Körner, A., Axelsson, H., Wang, W., Lundholm, K., & Svanberg, E. (2000) · PubMed · Cited by 134
Strassmann, G., Fong, M., Freter, C. E., Windsor, S., D'Alessandro, F., & Nordan, R. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116816 · Cited by 131
Kaliman, P., Canicio, J., Testar, X., Palacı́n, M., & Antonio Zorzano, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17437 · Cited by 129
Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor
Ohana, G., Bar‐Yehuda, S., Barer, F., & Fishman, P. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200101)186:1 · Cited by 123
Sitcheran, R., Cogswell, P. C., & Baldwin, A. S. (2003) · Genes & Development · doi:10.1101/gad.1114503 · Cited by 120
Protein Kinase B β/Akt2 Plays a Specific Role in Muscle Differentiation
Vandromme, M., Rochat, A., Meier, R., Carnac, G., Besser, D., Hemmings, B. A., Fernandez, A., & Lamb, N. J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005587200 · Cited by 112
TNFα inhibits skeletal myogenesis through a PW1‐dependent pathway by recruitment of caspase pathways
Coletti, D., Yang, E., Marazzi, G., & Sassoon, D. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.631 · Cited by 108
A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle
Nishi, M., Yasue, A., Nishimatu, S., Nohno, T., Yamaoka, T., Itakura, M., Moriyama, K., Ohuchi, H., & Noji, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00209-7 · Cited by 90
Myostatin in Muscle Growth and Repair
Sharma, M., Langley, B. C., Bass, J. J., & Kambadur, R. (2001) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200110000-00004 · Cited by 84
Baghdiguian, S., Richard, I., Martin, M., Coopman, P. J. P., Beckmann, J. S., Mangeat, P. H., & Lefranc, G. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100225 · Cited by 64
Inhibition of the initial wave of NF‐κB activity in rat muscle reduces ischemia/reperfusion injury
Lille, S. T., Lefler, S. R., Mowlavi, A., Suchy, H., Boyle, E. M., Farr, A. L., Su, C., Frank, N., & Mulligan, D. C. (2001) · Muscle & Nerve · doi:10.1002/mus.1037 · Cited by 47
Nuclear Factor κB-inducing Kinase and IκB Kinase-α Signal Skeletal Muscle Cell Differentiation
Canicio, J., Ruiz‐Lozano, P., Carrasco, M., Palacı́n, M., Chien, K. R., Zorzano, A., & Kaliman, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100718200 · Cited by 39
Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation
Fujio, Y., Mitsuuchi, Y., Testa, J. R., & Walsh, K. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400919 · Cited by 38
Dee, K., DeChant, A. K., & Weyman, C. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00571-4 · Cited by 9
Allen (1999) · doi:10.1002/(sici)1097-4652(199907)180:1
Research works printed but not linked: 2
- Zachwieja, 1999, J Grav Physiol, 6, 11
- Cahlin, 2000, Cancer Res, 60, 5488
Cited by
Sorted by citations
The intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Lenk, K., Schuler, G. C., & Adams, V. (2010) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-010-0007-1 · Cited by 498
Nuclear factor-kappa B signaling in skeletal muscle atrophy
Li, H., Malhotra, S., & Kumar, A. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0373-8 · Cited by 464
The p38 MAPK signaling pathway: A major regulator of skeletal muscle development
Keren, A., Tamir, Y., & Bengal, E. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.03.017 · Cited by 372
Jemtel, T. H. L., Padeletti, M., & Jelić, S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.046 · Cited by 321
Metadata
- Authors
- Guttridge, D. C.
- Venue
- Current Opinion in Clinical Nutrition and Metabolic Care
- Published
- 2004-07
- Volume
- 7
- Issue
- 4
- Pages
- 443-450
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W1990872004
- Cited by
- 149
- References
- 70
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 4 · 2015: 8 · 2014: 7 · 2013: 13 · 2012: 7
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- muscle hypertrophy, muscle atrophy, PI3K/Akt signaling, myostatin, NF-κB, insulin-like growth factor I, mTOR, p70S6K, TSC2, MyoD, myogenesis, protein synthesis
- MeSH terms
- Animals, Humans, Muscular Atrophy, Protein Kinases, Proto-Oncogene Proteins, Somatomedins, Signal Transduction, Transforming Growth Factor beta, NF-kappa B, Protein Serine-Threonine Kinases, Muscle, Skeletal, Proto-Oncogene Proteins c-akt, Myostatin, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review